FDA News: FDA Approved Spinraza

The FDA approved Spinraza (nusinersen), by Biogen, the first drug approved to treat children and adults with spinal muscular atrophy (SMA), SMA is a rare and often fatal genetic disease affecting muscle strength and movement. Spinraza is an injection administered into the fluid surrounding the spinal cord. SMA is a hereditary disease that causes weakness … Continued

FDA News: Jardiance Approval

December 2016 The FDA approved a new indication for Jardiance by Boehringer Ingelheim Pharmaceuticals, Inc., to reduce the risk of cardiovascular death in adult patients with type 2 diabetes mellitus and cardiovascular disease. Death from cardiovascular disease is 70 percent higher in adults with diabetes compared to those without diabetes. Patients with diabetes have a decreased … Continued

FDA News: Lartruvo for STS

The FDA granted accelerated approval to Lartruvo for STS (olaratumab). This infusion is produced by Eli Lilly and Company, to treat adults with certain types of soft tissue sarcoma (STS). It is approved for use with doxorubicin for the treatment of STS patients: Who cannot be cured with radiation or surgery. For which chemotherapy is … Continued

Type II Diabetes: Auto Insulin Delivery

FDA approved Medtronic’s MiniMed 670G hybrid closed looped system, the first FDA-approved device that is intended to automatically monitor glucose (sugar) and provide appropriate basal insulin doses in people 14 years of age and older with type 1 diabetes. The MiniMed 670G hybrid closed looped system, often referred to as an “artificial pancreas,” is intended … Continued